Astellas’ Patent Battles: Prior Art Challenges for US12097189B1
Astellas Pharma Inc. has initiated legal action against both Lupin Limited and Zydus Pharmaceuticals over patent US12097189B1. These lawsuits center around a modified-release pharmaceutical composition designed to optimize drug absorption